Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Pacific Biosciences of California Inc |
4/02 | 1,440 USD
-1,37% |
-1,37% |
|
Pacira BioSciences Inc |
4/02 | 26,590 USD
+3,26% |
+3,26% |
|
PainReform Ltd |
4/02 | 3,200 USD
+5,96% |
+5,96% |
|
Palatin Technologies Inc. |
4/02 | 0,800 USD
0,00% |
0,00% |
|
Passage Bio Inc |
4/02 | 0,610 USD
+6,36% |
+6,36% |
|
PAVmed Inc |
4/02 | 0,649 USD
-1,74% |
-1,74% |
|
PDS Biotechnology Corporation |
4/02 | 1,600 USD
+0,63% |
+0,63% |
|
Penumbra Inc |
4/02 | 262,110 USD
-1,09% |
-1,09% |
Perimeter Medical Imaging AI Inc |
4/02 | 0,800 CAD
+40,35% |
+40,35% |
|
Perrigo Company plc |
4/02 | 25,090 USD
0,00% |
0,00% |
|
Personalis Inc |
4/02 | 5,050 USD
+3,27% |
+3,27% |
|
Perspective Therapeutics Inc |
4/02 | 3,350 USD
+1,52% |
+1,52% |
|
PetVivo Holdings Inc |
4/02 | 0,760 USD
-5,00% |
-5,00% |
|
Pfizer |
4/02 | 25,870 USD
-1,26% |
-1,26% |
PharmaSGP Holding SE |
4/02 | 27,000 EUR
+0,75% |
+0,75% |
Pharming Group N.V. |
4/02 | 0,827 EUR
-1,19% |
-1,19% |
|
Pharming Group N.V. |
4/02 | 8,419 USD
+2,67% |
+2,67% |
|
Phathom Pharmaceuticals Inc |
4/02 | 6,050 USD
+7,46% |
+7,46% |
|
Phibro Animal Health Corp. |
4/02 | 22,020 USD
+1,54% |
+1,54% |
|
Philips |
4/02 | 25,940 EUR
-1,33% |
-1,33% |
|
Phio Pharmaceuticals Corp |
4/02 | 2,040 USD
0,00% |
0,00% |
|
Pieris Pharmaceuticals Inc |
13/12 | 13,600 USD
-15,69% |
-15,69% |
Plant Advanced Technologies Pat |
4/02 | 11,500 EUR
0,00% |
0,00% |
|
Pliant Therapeutics Inc |
4/02 | 11,370 USD
+1,70% |
+1,70% |
|
Plus Therapeutics Inc |
4/02 | 1,250 USD
+0,68% |
+0,68% |
Polarean Imaging Plc |
4/02 | 1,450 GBX
+3,57% |
+3,57% |
|
Polypid Ltd |
4/02 | 3,130 USD
+5,74% |
+5,74% |
|
Poseida Therapeutics Inc |
7/01 | 9,500 USD
-0,63% |
-0,63% |
|
Poxel |
4/02 | 0,270 EUR
-4,76% |
-4,76% |
|
Praxis Precision Medicines Inc |
4/02 | 83,490 USD
+4,02% |
+4,02% |
|
Precigen Inc |
4/02 | 1,330 USD
+2,31% |
+2,31% |
|
Precipio Inc |
4/02 | 6,611 USD
-0,59% |
-0,59% |
|
Precision Biosciences Inc |
4/02 | 5,010 USD
+7,28% |
+7,28% |
|
Predictive Oncology Inc |
4/02 | 1,500 USD
+7,91% |
+7,91% |
|
Prelude Therapeutics Inc |
4/02 | 1,110 USD
0,00% |
0,00% |
|
Prestige Consumer Healthcare Inc |
4/02 | 75,810 USD
+0,65% |
+0,65% |
|
Profound Medical Corp |
4/02 | 6,220 USD
-1,74% |
-1,74% |
|
ProMIS Neurosciences Inc. |
4/02 | 0,925 USD
+0,60% |
+0,60% |
|
ProPhase Labs Inc |
4/02 | 0,237 USD
-11,24% |
-11,24% |
|
ProQR Therapeutics N.V |
4/02 | 2,200 USD
-2,22% |
-2,22% |
|
Protagonist Therapeutics Inc |
4/02 | 37,580 USD
+1,02% |
+1,02% |
|
Protara Therapeutics Inc |
4/02 | 5,110 USD
+3,44% |
+3,44% |
|
Proteome Sciences plc |
3/02 | 4,390 GBX
0,00% |
0,00% |
|
Prothena Corporation plc |
4/02 | 14,490 USD
+7,81% |
+7,81% |
|
PTC Therapeutics Inc |
4/02 | 49,380 USD
-1,26% |
-1,26% |
|
Pulmatrix Inc |
4/02 | 7,030 USD
-6,27% |
-6,27% |
|
Pulmonx Corp |
4/02 | 5,770 USD
-1,20% |
-1,20% |
|
Pulse Biosciences Inc |
4/02 | 23,415 USD
+14,84% |
+14,84% |
|
Puma Biotechnology Inc |
4/02 | 2,820 USD
+1,08% |
+1,08% |
|
PureTech Health Plc |
4/02 | 147,200 GBX
-2,00% |
-2,00% |
|
PureTech Health Plc |
4/02 | 19,350 USD
-0,77% |
-0,77% |